Health Supernus Resubmits NDA for SPN-830 Apomorphine Infusion Device Eli Pacheco Dec 9, 2021 0 ROCKVILLE, Md., Dec. 08, 2021 (GLOBE NEWSWIRE) -- Supernus Pharmaceuticals, Inc. (NASDAQ: SUPN), a biopharmaceutical company focused on developing and commercializing products for the…